Sucampo Pharmaceuticals Inc (NASDAQ:SCMP)

Add to Watch List

Set Alert

7.30 Data as of Jun 17	+0.30 / +4.29% Today’s Change	3.78 Today\|\|\|52-Week Range 10.48	+48.98% Year-to-Date

7.30

Data as of Jun 17

+0.30 / +4.29%

Today’s Change

3.78

Today|||52-Week Range

10.48

+48.98%

Year-to-Date

SECTOR

Health Technology

INDUSTRY

Pharmaceuticals: Major

MARKET CAP

$293.8M

Company Description

Sucampo Pharmaceuticals, Inc. is a global pharmaceutical company. It is focused on innovative research, discovery, development and commercialization of proprietary drugs based on prostones and other novel drug technologies. Prostones, naturally occurring fatty acid metabolites that have emerged as promising compounds with unique physiological activities, can be targeted for the treatment of unmet or underserved medical needs. The company operates through three reportable segments, which disaggregates the business by geographic location: Americas, Europe and Asia. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD.

Contact Information

Sucampo Pharmaceuticals, Inc.

4520 East West Highway

Bethesda Maryland 20814-3392

P:(301) 961-3400

Investor Relations:
(240) 223-3718

www.sucampo.com

Employees

Shareholders

Other institutional	9.09%
Individual stakeholders	82.30%
Mutual fund holders	8.15%

Top Executives

Ryuji Ueno, MD, PhD	Chairman, Chief Executive & Scientific Officer
Andrew P. Smith, DBA	Chief Accounting Officer
Cary J. Claiborne, MBA	Chief Financial Officer
Taryn R. Joswick	Vice President-Clinical Development
Glenn Noronha, PhD	Vice President-Research & Development

To view my watchlist

Not a member yet?

jobs by

Search for jobs

Search All Jobs from Across the Web

About CNNMoney
Content
Magazines
Site Tools
Stay Connected
- My Account
- Mobile Site & Apps
- Facebook
- Twitter
- LinkedIn
- YouTube
- RSS Feeds
- Newsletters
- Tumblr
- Google+

Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2013 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones Indexes^SM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones Indexes^SM © 2013 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2013. All rights reserved. Most stock quote data provided by BATS.